Neglected tropical diseases (NTDs) pose a significant threat to the health of millions of people worldwide, particularly in impoverished populations in tropical and subtropical regions. The World Health Organization (WHO) considers certain fungal infections, such as chromoblastomycosis, as NTDs. Chromoblastomycosis is a chronic fungal infection affecting the skin and subcutaneous tissue, primarily found in tropical and subtropical regions of Latin America, Africa, and Asia. This case report presents a 46-year-old female patient with chromoblastomycosis who had a history of renal transplantation and was receiving immunosuppressive therapy. The patient exhibited dark, verrucous, and ulcerative lesions on the legs, and the diagnosis was confirmed through the microscopic examination of skin scrapings by observing medlar bodies. Two sequential fungal tissue cultures and ITS sequencing verified the presence of Alternaria infectoria, not formerly described in chromoblastomycosis. Moreover, observation of fly larvae in the lesions verified the diagnosis of myiasis. Treatment with voriconazole and terbinafine resulted in complete resolution of the lesions after 5 months. This case emphasizes the importance of considering chromoblastomycosis in individuals with occupational exposure in tropical areas, as well as the challenges associated with its diagnosis, coinfections, and treatment.
Dermatophytosis is a common skin infection worldwide. In recent years, Trichophyton mentagrophytes var. indotineae has rapidly emerged as a leading cause of recalcitrant dermatophytosis. Iran shows high genetic diversity within the T. mentagrophytes complex, suggesting local emergence of new genotypes, yet nationwide data remain limited. We performed a one-year multicentre, hospital-based survey of referred cases (September 2023–September 2024) in nine provinces of Iran to describe the current epidemiology of dermatophytosis and to analyse mutations in the squalene epoxidase (SQLE) gene associated with terbinafine (TRB) resistance. Clinical samples were obtained from 2211 patients with suspected dermatophytosis. Dermatophytes were recovered from 1568 samples (71%). Species-specific PCR identified T. mentagrophytes var. indotineae in 1191 cases (76%), confirming it as the dominant agent across all clinical forms, age groups and provinces. The remaining isolates comprised other dermatophytes, mainly other members of the T. mentagrophytes complex, T. tonsurans and Microsporum canis . Trichophyton mentagrophytes var. indotineae caused most cases of tinea cruris, tinea corporis, mixed infections and generalised dermatophytosis. It also accounted for 59% of tinea unguium and 37% of tinea capitis cases. No significant sex bias was observed and most patients were 20–49 years old. The data did not indicate recent introduction of the infection from outside Iran, supporting ongoing local transmission. SQLE sequencing of 410 isolates revealed resistance-associated mutations in 45% of strains, mainly F397L (72%) and L393S (28%), with the highest frequencies in southern provinces. ITS sequencing of a subset of isolates confirmed their identity as T. indotineae and revealed two ITS genotypes, including a dominant genotype VIII and a new sub-genotype XXIX. These findings show that T. indotineae is now the dominant dermatophyte in Iran and carries a substantial burden of SQLE mutations, highlighting the urgent need for continued molecular surveillance and antifungal stewardship.
Background: Invasive fungal infections (IFIs) are complications that lead to mortality and morbidity in hematologic malignancies. The time of starting antifungal therapy is vital. Preemptive antifungal therapy has appeared recently as a new policy for the management of IFIs based on noninvasive ways in neutropenic patients.Methods: We enrolled leukemia patients with neutropenia after chemotherapy in Imam Khomeini Hospital Complex, Tehran, Iran. Patients who entered the neutropenic phase were divided into two categories (empirical and preemptive) for receiving antifungal agents. The patients were clinically examined in the preemptive group every day to find IFIs. As soon as clinical evidence of IFIs was observed, antifungal was prescribed. The empirical group patients received antifungals based on the ward protocol. Based on the data in each group, the diagnostic and therapeutic results of cases are followed-up to 3 months. To compare percentages between the two groups, the chi-squared test was used. And to compare two means between the two groups, the independent t-test was used. All the statistical analyses were done in the Statistical Package for the Social Sciences (SPSS) version 24 software (IBM Corporation, Armonk, New York, USA).Results: We assessed 132 leukemic patients with inclusion and exclusion criteria. Eventually, 80 patients were enrolled. The mean age was 35.52 years. Demographics data and distribution of leukemia type show no significant differences between the two groups. Despite a higher percentage of IFIs discovered in the preemptive group than the empirical group (25 vs. 18.75%, respectively), but data show no significant differences. The average days of IFIs diagnosis since the beginning of neutropenia in the empirical group were 9.5 days while in the preemptive group, the average days were 5.4 days (p < 0.05). Totally, there were 15 patients with a proven IFI in each group (40% in the empirical group and 60% in the preemptive group). Results significantly show an increase in surgical sinus debridement in the empirical groups (83.3%) vs. the preemptive groups (55.5%), (p < 0.05). The mortality rate differed significantly among the two groups; it was 7.5% in the preemptive group and 25% in the empirical group (p < 0.05).Conclusion: Daily oral and nasal cavities examination to find the symptoms of IFIs and then start preemptive antifungal agents may be able to lead to accurate diagnosis, earlier treatment, and decreasing sinus surgery debridement in leukemia patients with neutropenia.